The new treatment, now available for the first time after clearance by Health Canada, has already been used on 15 patients at the MUHC.
A new study to be published in tomorrow's New England Journal of Medicine shows that United States investment in tuberculosis (TB) treatment abroad saves lives and money at home.
McGill epidemiologist Dr. Margaret Becklake is the lead author of a new study that suggests passive tobacco exposure is a predictor of whether a child will take up smoking.
Thirty-seven scientists from the Research Institute of the McGill University Health Centre received operating grants from the Canadian Institutes of Health Research (CIHR) in their most recent competition.
The new study, published in the "Proceedings of the National Academy of Science (PNAS)" this week, provides a new view of the mechanisms underlying the development of tuberculosis and may contribute to public health efforts aimed at containing the disease.
Scientists at the MUHC have made an important discovery that will advance our understanding of how the female hormone estrogen causes growth of breast cancer cells.